Detection and Verification of Mycobacterium avium subsp. paratuberculosis in Fresh Ileocolonic Mucosal Biopsy Specimens from Individuals with and without Crohn's Disease
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Mycobacterium avium subsp. paratuberculosis is a robust and phenotypically versatile pathogen which causes chronic inflammation of the intestine in many species, including primates. M. avium subsp. paratuberculosis infection is widespread in domestic livestock and is present in retail pasteurized cows' milk in the United Kingdom and, potentially, elsewhere. Water supplies are also at risk. The involvement of M. avium subsp. paratuberculosis in Crohn's disease (CD) in humans has been uncertain because of the substantial difficulties in detecting this pathogen. In its Ziehl-Neelsen staining-negative form, M. avium subsp. paratuberculosis is highly resistant to chemical and enzymatic lysis. The present study describes the development of optimized sample processing and DNA extraction procedures with fresh human intestinal mucosal biopsy specimens which ensure access to M. avium subsp. paratuberculosis DNA and maximize detection of these low-abundance pathogens. Also described are two nested PCR methodologies targeted at IS 900 , designated IS 900 [L/AV] and IS 900 [TJ1-4], which are uniquely specific for IS 900 . Detection of M. avium subsp. paratuberculosis in mucosal biopsy specimens was also evaluated by using mycobacterial growth indicator tube (MGIT) cultures (Becton Dickinson). IS 900 [L/AV] PCR detected M. avium subsp. paratuberculosis in 34 of 37 (92%) patients with CD and in 9 of 34 (26%) controls without CD (noninflammatory bowel disease [nIBD] controls) ( P = 0.0002; odds ratio = 3.47). M. avium subsp. paratuberculosis was detected by IS 900 [L/AV] PCR in MGIT cultures after 14 to 88 weeks of incubation in 14 of 33 (42%) CD patients and 3 of 33 (9%) nIBD controls ( P = 0.0019; odds ratio = 4.66). Nine of 15 (60%) MGIT cultures of specimens from CD patients incubated for more than 38 weeks were positive for M. avium subsp. paratuberculosis . In each case the identity of IS 900 from M. avium subsp. paratuberculosis was verified by amplicon sequencing. The rate of detection of M. avium subsp. paratuberculosis in individuals with CD is highly significant and implicates this chronic enteric pathogen in disease causation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Törnblom, H., Lindberg, G., Nyberg, B., & Veress, B. (2002) · Gastroenterology · doi:10.1053/gast.2002.37059 · Cited by 516 · cited 1×
“Recent studies (32) from Sweden with full-thickness jejunum biopsy specimens demonstrated that 9 of 10 individuals with IBS had clear evidence of enteric neuropathy with lymphocytic infiltration around the ganglia and the nerve fibers of the myenteric plexus.”
BackgroundMycobacterium paratuberculosis DNA in Crohn's disease tissue.
Sanderson, J. D., Moss, M. T., Tizard, M. L., & Hermon-Taylor, J. (1992) · Gut · doi:10.1136/gut.33.7.890 · Cited by 369
Self-citationCharacteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease
Chiodini, R. J., Van Kruiningen, H. J., Merkal, R. S., Thayer, W. R., & Coutu, J. A. (1984) · Journal of Clinical Microbiology · doi:10.1128/jcm.20.5.966-971.1984 · Cited by 291
Grant, I. R., Ball, H. J., & Rowe, M. T. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.5.2428-2435.2002 · Cited by 267
Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis
Geboes, K., & Collins, S. (1998) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.1998.00102.x · Cited by 255
Causation of Crohn’s Disease by Mycobacterium avium Subspecies Paratuberculosis
Hermon-Taylor, J., Bull, T. J., Sheridan, J. M., Cheng, J., Stellakis, M. L., & Sumar, N. (2000) · Canadian Journal of Gastroenterology · doi:10.1155/2000/798305 · Cited by 244
Self-citationCousins, D., Whittington, R., Marsh, I., Masters, A., Evans, R., & Kluver, P. (1999) · Molecular and Cellular Probes · doi:10.1006/mcpr.1999.0275 · Cited by 237
Role of enteric glial cells in inflammatory bowel disease
Cabarrocas, J., Savidge, T. C., & Liblau, R. S. (2003) · Glia · doi:10.1002/glia.10169 · Cited by 186
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics
Gui, G. P., Thomas, P. R., Tizard, M. L., Lake, J., Sanderson, J. D., & Hermon-Taylor, J. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.3.393 · Cited by 163
Self-citationCollins, M. T., Lisby, G., Moser, C., Chicks, D., Christensen, S., Reichelderfer, M., Høiby, N., Harms, B. A., Thomsen, O. Ø., Skibsted, U., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.12.4373-4381.2000 · Cited by 148
Schwartz, D., Shafran, I., Romero, C., Piromalli, C. S., Biggerstaff, J., Naser, N. A., Chamberlin, W., & Naser, S. A. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00093.x · Cited by 144
Shimoji, Y., Ng, V., Matsumura, K., Fischetti, V. A., & Rambukkana, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9857 · Cited by 141
Editors, T. M. A. F. C. D. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-1-3 · Cited by 121
Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease
Shafran, I., Kugler, L., Kl-Zaatari, F. A. X., Naser, S. A., & Sandoval, J. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80055-x · Cited by 114
Treatment of severe Crohn's disease using antimycobacterial triple therapy — approaching a cure?
Borody, T. J., Leis, S., Warren, E. F., & Surace, R. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80056-1 · Cited by 113
Cohavy, O., Harth, G., Horwitz, M. A., Eggena, M., Landers, C. J., Sutton, C. L., Targan, S. R., & Braun, J. G. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6510-6517.1999 · Cited by 99
IS902, an insertion element of the chronic-enteritis-causing Mycobacterium avium subsp. silvaticum
MOSS, M. T., Malik, Z., Tizard, M. L., Green, E. P., Sanderson, J. D., & Hermon-Taylor, J. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-1-139 · Cited by 82
Self-citationCharacterization of IS 1110, a highly mobiie genetic element from Mycobacterium avium
Perez, M. H., Fomukong, N. G., Hellyer, T. J., Brown, I. N., & Dale, J. W. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01059.x · Cited by 56
Cited by
Loftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,117
Gut microorganisms, mammalian metabolism and personalized health care
Nicholson, J. K., Holmes, E., & Wilson, I. D. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1152 · Cited by 945
“Recent studies that used spectroscopic profiling and pattern recognition methods have shown the importance of changes in the gut microbial community on host metabolis”
Naser, S. A., Ghobrial, G., Romero, C., & Valentine, J. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17058-x · Cited by 626
Feller, M., Huwiler, K., Stephan, R., Altpeter, E., Shang, A., Furrer, H., Pfyffer, G. E., Jemmi, T., Baumgartner, A., & Egger, M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70211-6 · Cited by 526
Kotlowski, R., Bernstein, C. N., Sepehri, S., & Krause, D. O. (2007) · Gut · doi:10.1136/gut.2006.099796 · Cited by 422
Metadata
- Authors
- Bull, T. J., McMinn, E. J., Sidi-Boumedine, K., Skull, A., Durkin, D., Neild, P., Rhodes, G., Pickup, R., & Hermon-Taylor, J.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2003-07
- Volume
- 41
- Issue
- 7
- Pages
- 2915-2923
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2120424719
- Cited by
- 403
- References
- 18
- FWCI
- 18.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.